Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2016
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Sanofi
- 02 Mar 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 21 Apr 2014 Trial status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Oct 2013 New trial record